• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Invesco Nasdaq Biotechnology ETF (NQ:IBBQ)

36.11 -0.18 (-0.50%)
Official Closing Price Updated: 4:15 PM EDT, Aug 24, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 49,296
Open 36.34
Bid (Size) 35.71 (8,400)
Ask (Size) 36.37 (8,200)
Prev. Close 36.29
Today's Range 35.73 - 36.34
52wk Range 23.25 - 36.84
Shares Outstanding N/A
Dividend Yield 0.38%
Chart for  (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
News headline image
Which Biotech ETF Is a Better Buy: Concentrated Bet or Broad Basket? ↗
August 22, 2026
VanEck's concentrated 25-stock approach offers higher individual company exposure, while Invesco's broader 251-position portfolio delivered 47.4% returns over the past year. 
Via The Motley Fool
Topics ETFs
News headline image
IBBQ vs. PBE: Which Biotech ETF Is the Better Buy? ↗
August 21, 2026
PBE concentrates on 31 companies and offers a higher dividend yield, while IBBQ spreads risk across 251 holdings at a fraction of the cost. 
Via The Motley Fool
Topics ETFs

Performance

YTD
+27.3%
+27.3%
1 Month
+11.9%
+11.9%
3 Month
+22.8%
+22.8%
6 Month
+20.5%
+20.5%
1 Year
+55.3%
+55.3%

More News

Read More
News headline image
Invesco Nasdaq Biotech vs. Invesco Pharma: How Do These ETFs Stack Up? ↗
August 19, 2026
Via The Motley Fool
Topics ETFs
uniQure Stock Tumbled 56% Today: What’s The FDA Angle? ↗
November 03, 2025
Via Stocktwits
News headline image
Which Is the Better Invesco Healthcare ETF: Equal-Weight RSPH or Biotech-Focused IBBQ? ↗
August 12, 2026
Via The Motley Fool
Topics ETFs
News headline image
XLV vs. IBBQ: Is Broad Healthcare Exposure or Biotech Growth the Better ETF Buy? ↗
August 01, 2026
Via The Motley Fool
Topics ETFs Intellectual Property
News headline image
Better Healthcare Sector ETF: Vanguard's Broad VHT vs. Invesco's Biotechnology-Focused IBBQ ↗
July 26, 2026
Via The Motley Fool
Topics ETFs
News headline image
Is the iShares Healthcare ETF or the Invesco Nasdaq Biotech ETF the Better Bet for Investors in 2026? ↗
July 22, 2026
Via The Motley Fool
Topics ETFs
News headline image
IXJ vs. IBBQ: Global Healthcare vs. Biotech -- Which ETF Is the Better Buy? ↗
July 18, 2026
Via The Motley Fool
Topics ETFs
News headline image
Which is Best for Investors: Healthcare Stability (XLV) or Biotech Growth (IBBQ)? ↗
July 11, 2026
Via The Motley Fool
Topics ETFs
News headline image
Which Healthcare ETF Is the Better Buy: Invesco's IBBQ or State Street's XPH? ↗
July 08, 2026
Via The Motley Fool
Topics ETFs
News headline image
Biotech ETFs: Which ETF Offers Lower Fees? IBBQ or XPH? ↗
June 04, 2026
Via The Motley Fool
Topics ETFs
News headline image
Alvotech’s Drug Approved In Europe As Biosimilar For Bone Disease Drug ↗
November 24, 2025
Via Stocktwits
News headline image
Applied Therapeutics To Lay Off Nearly Half Its Staff, Board Explores M&A Options ↗
November 20, 2025
Via Stocktwits
Topics Workforce
News headline image
Artiva Biotherapeutics Gets A Price Target Hike From Wedbush: Stock Rallies 99% But Retail Expects Further Rally ↗
October 17, 2025
Via Stocktwits
News headline image
Mesoblast Gives Positive Update About Potential FDA Application For Heart Failure Therapy: Retail Sees ‘Inflection Point’ ↗
June 12, 2025
Via Stocktwits
News headline image
These 4 ETFs Provide Smart Exposure To Intuitive Machines, The New Space Economy ↗
March 21, 2025
Via Benzinga
Topics ETFs
News headline image
5 Undervalued ETFs To Ride On Powell's Market Optimism ↗
March 20, 2025
Via Talk Markets
Topics ETFs
News headline image
Tempus AI Stock Eyes Best Rally In 5 Months Amid Pelosi-Linked Hype, But Retail’s Turning Doubtful Now ↗
January 23, 2025
Via Stocktwits
Topics Artificial Intelligence
News headline image
FDA Set To Approve COVID-19 Vaccines As Soon As This Week: Stocks, ETFs To Watch ↗
August 19, 2024
Via Benzinga
Topics ETFs
News headline image
Time For Gilead Sciences-Heavy ETFs? ↗
September 12, 2023
Via Talk Markets
News headline image
Biotech ETFs Pop On M&A Resurgence ↗
May 10, 2023
Via Talk Markets
News headline image
Is Biotech Immunocore About To Make A 25% Price Move?
February 07, 2023
Via MarketBeat
Topics ETFs
News headline image
Should You Buy Biotech ETFs Now? ↗
June 16, 2021
Via Talk Markets

Frequently Asked Questions

Is Invesco Nasdaq Biotechnology ETF publicly traded?
Yes, Invesco Nasdaq Biotechnology ETF is publicly traded.
What exchange does Invesco Nasdaq Biotechnology ETF trade on?
Invesco Nasdaq Biotechnology ETF trades on the Nasdaq Stock Market
What is the ticker symbol for Invesco Nasdaq Biotechnology ETF?
The ticker symbol for Invesco Nasdaq Biotechnology ETF is IBBQ on the Nasdaq Stock Market
What is the current price of Invesco Nasdaq Biotechnology ETF?
The current price of Invesco Nasdaq Biotechnology ETF is 36.11
When was Invesco Nasdaq Biotechnology ETF last traded?
The last trade of Invesco Nasdaq Biotechnology ETF was at 08/24/26 04:15 PM ET
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap